selected publications
-
Atherosclerosis: immunopathogenesis and strategies for immunotherapy.
Immunotherapy.
2021
Review
GET IT
Times cited: 28 -
Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species.
Biomolecules.
2021
Academic Article
GET IT
Times cited: 6 -
Submerged cultivation, characterization and in vitro antitumor activity of polysaccharides from Schizophyllum radiatum.
International journal of biological macromolecules.
2021
Academic Article
GET IT
Times cited: 32 -
Biotechnological production, characterization and in vitro antitumor activity of polysaccharides from a native strain of Lentinus crinitus.
International journal of biological macromolecules.
2020
Academic Article
GET IT
Times cited: 19 -
Genomic Analysis of Colombian Leishmania panamensis strains with different level of virulence.
Scientific reports.
2018
Academic Article
GET IT
Times cited: 18 -
Antitumor activity of Lepidium latifolium and identification of the epithionitrile 1-cyano-2,3-epithiopropane as its major active component.
Molecular carcinogenesis.
2017
Academic Article
GET IT
Times cited: 13 -
Interleukin-10 production and T cell-suppressive capacity in B cell subsets from atherosclerotic apoE -/- mice.
Immunologic research.
2017
Academic Article
GET IT
Times cited: 7 -
Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
PLoS neglected tropical diseases.
2017
Academic Article
GET IT
Times cited: 46 -
Data in support of dyslipidemia-associated alterations in B cell subpopulations frequency and phenotype during experimental atherosclerosis.
Data in brief.
2016
Academic Article
GET IT
Times cited: 2 -
C-Geranylated flavonoids from Paulownia tomentosa fruits with antimicrobial potential and synergistic activity with antibiotics.
Pharmaceutical biology.
2016
Academic Article
GET IT
Times cited: 18 -
Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis.
Atherosclerosis.
2015
Academic Article
GET IT
Times cited: 10 -
Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.
Nanomedicine (London, England).
2012
Academic Article
GET IT
Times cited: 27 -
In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites.
PLoS neglected tropical diseases.
2012
Academic Article
GET IT
Times cited: 49 -
New polyether triterpenoids from Laurencia viridis and their biological evaluation.
Marine drugs.
2011
Academic Article
GET IT
Times cited: 44 -
Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells.
Anti-cancer drugs.
2011
Academic Article
GET IT
Times cited: 43 -
Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria.
Cell death & disease.
2011
Academic Article
GET IT
Times cited: 57 -
Cytotoxic oxasqualenoids from the red alga Laurencia viridis.
European journal of medicinal chemistry.
2011
Academic Article
GET IT
Times cited: 42 -
Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils.
The Journal of biological chemistry.
2010
Academic Article
GET IT
Times cited: 60 -
Lipid raft-targeted therapy in multiple myeloma.
Oncogene.
2010
Academic Article
GET IT
Times cited: 101 -
In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2010
Academic Article
GET IT
Times cited: 83